Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Chief Revenue Officer | September 28, 2021 | September 29, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date September 28, 2021 · Filed September 29, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Twenty Two Capital LLC | 0 |
Reported balance
After 2021-09-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-09-28 · Other · Disposed 161,550 · Balance 0 F1: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. F2: Represents the Reporting Person's pecuniary interest in the 300,000 shares of the Issuer acquired by Twenty Two pursuant to the APA. The Reporting Person is the holder of a 53.85% membership interest in Twenty Two and a manager of Twenty Two. |
| Common StockSEC Table I · non-derivative | Direct | 176,450 |
Reported balance
After 2021-09-28 transaction · row 2
1 source rowRow 2 · 2021-09-28 · Other · Acquired 150,450 · Balance 176,450 F1: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3.
F2: Represents the Reporting Person's pecuniary interest in the 300,000 shares of the Issuer acquired by Twenty Two pursuant to the APA. The Reporting Person is the holder of a 53.85% membership interest in Twenty Two and a manager of Twenty Two.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2021 Filed Sep 29, 2021 18:01 UTC | cbdMD, Inc. YCBD · Entity 8230 | OtherCommon Stock | 150,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010548 · section16.xml · nonDerivative · entry 2 Wiesehan John J III · CIK 0001875037 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,450 F1 · kind: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. F1 · price: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 18:01 UTC | cbdMD, Inc. YCBD · Entity 8230 | OtherCommon Stock | 161,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010548 · section16.xml · nonDerivative · entry 1 Wiesehan John J III · CIK 0001875037 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Twenty Two Capital LLC Disclosed balance after: 0 F1 · kind: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. F1 · price: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3. F2 · ownership.nature: Represents the Reporting Person's pecuniary interest in the 300,000 shares of the Issuer acquired by Twenty Two pursuant to the APA. The Reporting Person is the holder of a 53.85% membership interest in Twenty Two and a manager of Twenty Two. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 12:12 UTC | cbdMD, Inc. YCBD · Entity 8230 | Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative | 2,000 | $6.97 Strike: $6.00 | $13,940.00 |
DisclosureSEC source: 0001654954-21-009280 · section16.xml · derivative · entry 1 Wiesehan John J III · CIK 0001875037 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 3,334 shares Expires not disclosed F1 · derivative.exercise_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date. F1 · derivative.expiration_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 17:31 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon Stock | 161,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-008222 · section16.xml · nonDerivative · entry 1 Wiesehan John J III · CIK 0001875037 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Twenty Two Capital LLC Disclosed balance after: 161,550 F1 · price: The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement, dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein (the "APA"). Pursuant to the APA, the Issuer agreed to acquire certain assets, including among others, tangible personal property, inventories, accounts receivable, contracts, governmental authorizations, intangible rights and property, and insurance benefits, subject to certain exclusions, in exchange for (i) $2,000,000 in cash, subject to adjustment per the APA, (ii) 600,000 shares of the Issuer's common stock, with (x) 300,000 shares issued at closing, (y) 100,000 shares to be issued on or before January 31, 2023, subject to certain set-off obligations, and (z) the remainder to be issued on or before the 60th day following the first year anniversary of the closing, subject to certain adjustments, and assume certain liabilities as provided for in the APA. F2 · ownership.nature: Represents the Reporting Person's pecuniary interest in the 300,000 shares of the Issuer acquired by Twenty Two pursuant to the APA. The Reporting Person is the holder of a 53.85% membership interest in Twenty Two and has shared voting and investment power over its portfolio securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.